Bearishness Around Pfizer Gilead Sparks Opportunity
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Understand the key factors for determining when to sell stocks and buy bonds to optimize your investment strategy.
28,656 articlesWall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Scorpio Tankers has moved from a debt-laden balance sheet to net cash of roughly $334 million by early 2026, a develo...
Moderna and Ross Stores surged midweek on distinct catalysts: a patent settlement clearing a key overhang for Moderna...
With $500 in hand, the big question is where to invest for the best balance of growth and risk. This article compares...
A seven-name AI hardware rally is reshaping bets for 2026, with Parabolic 7 outpacing the Magnificent 7 and drawing n...
Two Wall Street giants raised price targets on Super Micro Computer after a solid Q3 2026 performance, but neither mo...
Oracle's AI strategy is under scrutiny as earnings shed light on backlog and cash needs. We see roughly 46-47% upside...
A new ETF from Alpha Architect is drawing attention for tax-driven gains. BOXX aims to cut taxes for high earners by ...
As market conditions shift, financial institutions are prioritizing customer value matters more to shape loan product...
A 70-year-old couple faced a $19,000 yearly Massachusetts tax bill after keeping a Boston home while establishing Flo...
A trader alleges Polymarket unfairly resolved a market tied to MicroStrategy's bitcoin sale, claiming a post-deadline...
Broadcom beat on revenue but missed AI-growth expectations, sparking a rethink on how investors price AI-driven momen...